Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat

Hypertension

Volumn 28, Issue 5, 1996, Pages 743-753

  Xue, Chun ^a   Johns, Roger A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

anoxia; cGMP; endothelium, vascular; guanylate cyclase; hypertension, pulmonary; muscle, smooth, vascular; nitric oxide; nitric oxide synthase

Indexed keywords

DNA; GUANYLATE CYCLASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; VASCULAR ENDOTHELIUM;

EID: 0029957529     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.5.743     Document Type: Article

References (47)

1. Abraham AS, Kay JM, Cole RB, Pincock AC. Hemodynamic and pathological study of the effect of chronic hypoxia and subsequent recovery of the heart and pulmonary vasculature of the rat. Cardiovasc Res. 1971;5:95-102.
2. Hislop A, Reid LM. Formation of the pulmonary vasculature. In: Hodson WA, ed. Development of the Lung. New York, NY: Marcel Dekker; 1977:37-86.
3. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol. 1979;236:H818-H827.
4. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun. 1989; 164:1198-1205.
5. Voelkel NF. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis. 1986;133:1186-1195.
6. Dinh-Xuan AT. Disorders of endothelium-dependent relaxation in pulmonary disease. Circulation. 1993;87(suppl V):V-81-V-87.
7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
8. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
10. W-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol. 1991;260:H299-H306.
11. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am J Physiol. 1992; 262:H1365-H1371.
12. Hasunuma K, Yamaguchi T, Rodman DM, O'Brien RF, McMurtry IF. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am J Physiol. 1991;260:L97-L104.
13. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest. 1991;87:155-162.
14. Dinh-Xuan AT, Higenbottam TW, Clelland MB, Pepke-Zaba J, Cremona G, Wallwork J. Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol. 1989; 163:401-403.
15. Dinh-Xuan AT, Higenbottam TW, Clelland MB, Pepke-Zaba J, Cremona G, Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol. 1990;99:9-10.
16. Dinh-Xuan AT, Higenbottam TW, Colin A, Clelland MB, Pepke-Zaba J, Cremona G, Butt AY, Large SP, Well FC, Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med. 1991;324: 1539-1547.
17. Dinh-Xuan AT, Higenbottam TW, Wallwork J. Relationship between chronic hypoxia and in vitro pulmonary relaxation mediated by endothelium-derived relaxing factors in human chronic obstructive lung disease. Angiology. 1992;43:350-356.
18. Barer GR, Emery CJ, Bee D, Wach RA. Mechanisms of pulmonary hypertension: an overview. In: Will JA, Dawson CA, Weir EK, Buckner CK, eds. The Pulmonary Circulation in Health and Disease. Orlando, Fla: Academic Press; 1987:409-422.
19. Hampl V, Archer SL, Nelson DP, Weir K. Chronic EDRF inhibition and hypoxic effects on pulmonary circulation and systemic blood pressure. J Appl Physiol. 1993;75:1748-1757.
20. Hampl V, Cornfield DN, Cowan NJ, Archer SL. Hypoxia potentiates nitric oxide synthase and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells. Eur Respir J. 1995;8: 515-522.
21. Leeman M, de Beyl VZ, Delcroix M, Naeije R. Effects of endogenous nitric oxide on pulmonary vascular tone in intact dogs. Am J Physiol. 1994;266:H2343-H2347.
22. Shaul PW, Wells LB, Horning KM. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J Cardiovasc Pharmacol. 1993;22: 819-827.
23. Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, Star RA. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol. 1995;13:167-174.
24. Xue C, Rengasamy A, Le Cras TD, Koberna PA, Dailey GC, Johns RA. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am J Physiol. 1994;267: L667-L678.
25. Roos CM, Frank DU, Xue C, Johns RA, Rich GF. Chronic inhaled nitric oxide: effects on pulmonary endothelial function and pathology in hypoxic and normoxic rats. J Appl Physiol. 1996;80:252-260.
26. Le Cras TD, Xue C, Dailey GC, Johns RA. Endothelial NO synthase mRNA and protein, and inducible NO synthase mRNA are upregulated in the rat lung following chronic hypoxia. Am J Respir Crit Care Med. 1995;151:A729.
27. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
28. Xue C, Johns RA. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333: 1642-1644.
29. Xue C, Pollock J, Schmidt HHHW, Ward SM, Sanders KM. Expression of nitric oxide synthase immunoreactivity by interstitial cells of the canine proximal colon. J Auton Nerv Syst. 1994;49:1-14.
30. Xue C, Reynolds PR, Johns RA. Developmental expression of NOSs in fetal rat lung: implications for transitional circulation and pulmonary angiogenesis. Am J Physiol. 1996:L88-L100.
31. Zuo Z, Johns RA. Halothane, enflurane, and isoflurane do not affect the basal or agonist-stimulated activity of partially isolated soluble and particulate guanylyl cyclases of rat brain. Anesthesiology. 1995; 83:395-404.
32. Kourembanas S, Bernfield M. Hypoxia and endothelial-smooth muscle cell interactions in the lung. Am J Respir Cell Mol Biol. 1994; 11:373-374.
33. Johns RA, Linden JM, Peach MJ. Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res. 1989;65:1508-1515.
34. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
35. Hassid A, Arabshahi H, Bourcier T, Phaursi GS, Matthews C. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am J Physiol. 1994;267:H1040-H1048.
36. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A. 1995;92: 4292-4296.
37. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol. 1993;239:215-217.
38. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P, Yaffee M. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta. 1995;1271:67-74.
39. Tracey WR, Xue C, Klinghofer V, Barlow J, Pollock JS, Forstermann U, Johns RA. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol. 1994;266:L722-L727.
40. Nunokawa Y, Nobuhiro I, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89-94.
41. Chu SC, Wu H, Banks TC, Eissa NT, Moss J. Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem. 1995;270:10625-10630.
42. Rengasamy A, Xue C, Johns RA. Immunohistochemical demonstration of a paracrine role of nitric oxide in bronchial function. Am J Physiol. 1994;267:L704-L711.
43. Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest. 1992;90:421-428.
44. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
45. North AJ, Star RA, Brannon TS, Ujiie K, Wells LB, Lowenstein CJ, Snyder SH, Shaul PW. Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung. Am J Physiol. 1994;266:L635-L641.
46. Isaacson TC, Hampl V, Weir K, Nelson DP, Archer SL. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol. 1994;76:933-940.
47. Iadecola C, Xu X, Zhang F, El-Fakahany EE, Ross ME. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab. 1995; 15:52-59.